Valuation: Celltrion, Inc.

Market Cap 38,348B 24.73B 21.71B 19.99B 18.62B 35.12B 2,351B 35.84B 240B 93.14B 1,154B 92.86B 90.85B 4,017B P/E 2026 *
29.4x
P/E 2027 * 24.1x
Enterprise Value 40.44B 26.08M 22.9M 21.08M 19.64M 37.04M 2.48B 37.79M 254M 98.22M 1.22B 97.93M 95.81M 4.24B EV / Sales 2026 *
7.6x
EV / Sales 2027 * 6.42x
Free-Float
53.67%
Yield 2026 *
0.43%
Yield 2027 * 0.45%
1 day+0.69%
1 week+8.72%
Current month+0.69%
1 month-5.02%
3 months-7.09%
6 months+1.23%
Current year+1.23%
1 week 161,100
Extreme 161100
180,300
1 month 158,500
Extreme 158500
182,571.43
Current year 158,500
Extreme 158500
239,047.62
1 year 153,142.86
Extreme 153142.8571
239,047.62
3 years 114,250.83
Extreme 114250.8285
239,047.62
5 years 114,250.83
Extreme 114250.8285
247,058.06
10 years 64,487.59
Extreme 64487.5934
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 20/03/2015
Chief Executive Officer 42 26/03/2021
President 50 13/02/2026
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 01/04/2005
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap.
01-16Sell 1,000 0.0004%
01-16Sell 1,000 0.0004%
01-16Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.69%+8.72%+14.80%+30.86% 24.59B
+3.08%+9.20%-0.42%+5.47% 47.18B
+0.12%+10.45%+408.29%+598.88% 39.82B
+5.17%+9.47%+24.96%-8.08% 32.25B
+2.02%+4.91%+18.59%+60.76% 31.68B
+0.40%+12.51% - - 16.57B
+2.64%+6.00%+69.30%+127.40% 15.12B
-0.15%+4.94%+13.27%+17.71% 13.69B
-0.13%+3.49%+98.27%+92.77% 13.1B
+0.77%+10.67%+17.58%-27.97% 13.31B
Average +1.43%+8.81%+73.85%+99.76% 24.73B
Weighted average by Cap. +1.76%+8.18%+89.91%+128.02%

Financials

2026 *2027 *
Net sales 5,325B 3.43B 3.01B 2.78B 2.59B 4.88B 326B 4.98B 33.38B 12.93B 160B 12.89B 12.61B 558B 6,171B 3.98B 3.49B 3.22B 3B 5.65B 378B 5.77B 38.69B 14.99B 186B 14.94B 14.62B 646B
Net income 1,397B 901M 791M 728M 679M 1.28B 85.66B 1.31B 8.76B 3.39B 42.05B 3.38B 3.31B 146B 1,687B 1.09B 955M 879M 819M 1.55B 103B 1.58B 10.58B 4.1B 50.77B 4.09B 4B 177B
Net Debt 2,093B 1.35B 1.19B 1.09B 1.02B 1.92B 128B 1.96B 13.12B 5.08B 63B 5.07B 4.96B 219B 1,267B 817M 717M 660M 615M 1.16B 77.67B 1.18B 7.94B 3.08B 38.13B 3.07B 3B 133B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,680
Date Price Change Volume
01/07/26 174,500.00 +0.69% 473,079
30/06/26 ₩173,300.00 -3.29% 565,686
29/06/26 ₩179,200.00 +8.02% 765,680
26/06/26 ₩165,900.00 -4.16% 596,116
25/06/26 ₩173,100.00 +0.23% 631,651
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
174,500.00KRW
Average target price
254,025.79KRW
Spread / Average Target
+45.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock